Who We Are How It Works Current Projects Past Studies Contact Us Back to Home Page
  "dedicated to creating new and effective methods of successfully treating viruses and bacteria using bio-energetic frequencies that do no harm to the individual being treated."  

Published in the TOWNSEND LETTER for DOCTORS - JUNE 1994 pages 606 -607

View Accompanying Graph

Suppression of Frequently Recurring Herpes

Introduction: The suppression of frequently recurring herpes, by the delivery of homeopathic medications via audio cassette technology. A placebo-controlled double blind trial.

By Michael Kelly, President, ThoughtForms Corporation

With the invention of electroacupuncture according to Voll, (EAV, Germany 1953), and later improvements such as the MORA-Therapy Unit (1975); it us now possible for health care practitioners to administer homeopathic remedies electronically.

EAV technology transfers the remedies, i.e. swallowing, or having a substance injected into their physical body. All of this is possible without affecting the nature of potency of the original test set of homeopathic remedies used by the practitioner!

ThoughtForms Corporation of Minneapolis has developed a similar patented process to transfer homeopathic remedies onto audio cassette tapes. Just as a liquid homeopathic remedy can be produce in a pill form, ThoughtForms Corporation has taken the liquid and produced it in a electronic form on magnetic tapes for use by the general public which eliminates the need for repurchasing the product at a later date for repeated use.

Summary of A Placebo-Controlled Double Blind Trial of Michael Kelly's Audio Cassette Technology. Conducted by Donald Soli, M.D.


Twenty-six other wise healthy adults with frequently recurring herpes, both simple-1 and simmple-2 (>6 episodes per year). Were studied in a double blind trial comparing two audio cassettes provided by Michael Kelly, for the suppression of recurrent herpes infections. The patients were treated five times during the 60 days unless herpes recurred. If the patients experienced a recurrent infection they were seen at the clinic within 24-48 hrs, examined, and treated again with their assigned audio cassette. Twenty-three patients completed the testing. Among the 23 evaluable patients, there were significantly fewer recurrences (3 out of 4) in patients using the tape K (real) than in patients using the tape M / placebo tape (8 out of 10)

The duration of therapy (60 days) was the same for all patients.

It was concluded that Michael Kelly's tape K (real tape) suppresses simplex-1 and simplex -2 herpes in patients with frequent recurrences.

Due to the limited duration of testing, it was unknown whether the tape eliminates the latent virus in nerve ganglia i.e. whether the infection recurs after treatment. Despite this limitation, this study suggests that Michael Kelly's audio is useful for the suppression of expected herpetic recurrences.


Study Population

All patients studied were other wise healthy patients between 17 and 60 years of age who had reported 6 or more recurrences in the past year, and who agreed to abstain form using any other medications or treatment methods, and agreed to practice effective methods of birth control.

Study Design

Mr. Kelly provided me with a tape "K" and a tape "M" . I was further informed that one of the tapes was a placebo while the other contained Mr. Kelly's remedies, but was not informed as tow which was which. Both tapes contained the sound of relaxing music and the sound of running water and were apparently identical in length. Appearance, and sound. At the initial visit, informed consent and medical histories were obtained, suspected lesions were examined, and the patients were assigned to the tape "K" or the tape "M". Two coded audio cassettes were used in the medical office with each visit by volunteers. One cassette tape was identified as (M) and one was identified as cassette (K). The first three consecutive days each vounteer was tested and treated and then scheduled to return once per month for two additional visits. During the first visit after a medical history was taken, each person had blood drawn and then they were tested with Voll's Dermatron, a diagnostic device that measures electrical energy emitted by acupuncture points. After measurements were taken all patients were instructed to listen once to the assigned 20-minute cassette with headphones. Each patient has handed the cassette by the physician's assistant and then listened to the cassette once per day, with each visit when they arrived in the clinic for test in during the first three days of the study. Clinic visits were scheduled once every 4 weeks. Additional visits were arranged as needed to evaluate suspected recurrences within 24 hours after onset. In the absence of a recurrence, the only treatment given every four weeks was listening to the audio tape once every month in the medical office. The entire test period was 60 day. We continue to monitor the patients with monthly phone interviews regarding any changes in the frequency of recurrences. A recurrence was diagnosed clinically when a patent present with typical symptoms and a number of vesicles, pustules, oar ulcers. Each patient was checked with the Voll Dermatron.

On confirmation of a recurrence (clinically) patients immediately were tested with the Dermatron and then treated with their assigned cassette either (K) or (M).

At the conclusion of the study, I opened an envelope that had been provided to me by Mr. Kelly prior to the study. The letter therein identified the "K" tape as the authentic treatment and the "M" tape as the placebo.

Monitoring of Toxicity and Compliance

At all visits, the subjects were questioned regarding signs or symptoms of herpetic disease, as well as any negative reactions to the treatment. There were no complaints about negative reactions from anyone in the (K) group. At each scheduled visit, each patient was tested with Dermatron and each then listened to their assigned tape.

Virus Isolation

Viral identification was conducted with the Dermatron and blood test were taken on the first visit and on the last visit. Due to the late date that testing was completed, these test have not been analyzed or reviewed.


Twenty-six patients were enrolled in the study. Twenty-three patients completed the treatment. The data form three patients were not included in the analysis of the results of treatment. Two women using the treatment tape (K) withdrew from the study, and one man using the placebo tape (M) withdrew. None of those who withdrew reported any outbreaks of the herpes virus before discontinuing.

Effects of Treatment

Table 2 shows the outcome of treatment of the study. Significantly fewer patients (3 patients in the tape (K) group vs. 8 in the (M) group) experienced recurrences.

Patient Statements

The positive experiences of four patients are noteworthy. The one woman n the (K) group who experienced a recurrence stated " I usually have outbreaks one week after my period. Normally it takes on week to scale over and dry up. It was amazing how it was down, a smaller breakout, clearing and gone in three days." A man, who started to have a recurrence on his lower lip stated, " it didn't materialize." Another stated normally he would have had two additional recurrences by now instead of actually experiencing none.

A third man in the (K) group experienced and outbreak the second day the test began. He healed in two days and stated, "this is the quickest it has ever healed." Since his infection occurred on the second day of the test, within the first three days of the test, it was not counted as a failure of the (K) tape. Another man in the (K) group who did not experience any recurrence stated "in the past month I would have normally had 2 out breaks, but nothing!"

Eleven out of 26 patients experienced recurrences. All recurrences were confirmed with clinical visits. Of these 11, 8 patients had used the placebo tape (M), and they had a total of 10 recurrences combined. Two patients from the tape (K) had recurrences, 2 outbreaks each.

Moreover, the mean times for healing from the onset of the first recurrence after the start of treatment were significantly shorter in the tape (K) group. Two patients said they healed in 57% less time (3 days instead of 7), and 50% less (3 days instead of 6), the third one healed at his normal rat of 6 days.

In the blind study, the (K) tape treatment failed in two of eight men and in one of three women. In the (M) group 5 women and 3 men had recurrences.

The Average Length of Recurrence

Prior to treatment, the patients reported their average duration of outbreaks as follows:
(M) Group = 11.58, 139 total days, 12 patients
(K) Group = 8.36, 92 total days, 11 patients
During treatment, the patients reported their average duration of outbreaks as follows:
(M) Group = 7.75 days, 62 total days / 8 patients 33.07% improvement
(K) Group = 4.66 days, 14 days total / 3 patients 44.25% improvement

It is believed some improvement in both groups is attributed to the relaxing nature of the music on both tapes as well as heightened expectations.

Additional Sample Data

Prior to test, the number of days most recent recurrence lasted:
Group (M) total 120 days, average 10
Group (K) total 98, average 8.9
The average age of the male and female participants
Men's average age = 33.34, low = 17, high = 58, total = 206
Women's average age = 28.8, low =20, high = 53, total = 173
The number of males 14, and females 12, 3 females dropped out.
Group (M) females 7, males 6, 1 female dropped out
Group (K) females 5, males 8, 2 females dropped out
Number of patients experiencing simplex-1, oral, or genital herpes, simplex-2
Group (M) 8 had simplex-1, 4 had simplex-2
Group (K) 5 had simplex-1, 2 had simplex-2 and 2 patients had both simplex 1 & 2.

None of the patients had more vesicles or reported more severe symptoms during the treatment recurrence than they recalled having had during their more recent pretreatment episodes.

In the (K) group there was two reports of tingling, characteristic of incipient recurrences: however, lesions did no t develop. After completing the treatment, all patients received copies of the tape containing the proper sound frequencies.


Compliance was verified by visits to the medical office and that is the only time patients had access to use the audio cassette tapes.

Two female patients moved out of state and were unable to complete the test. Another female patient dropped out of the study after being physically abused by her husband.

Adverse Reactions

No problems, related to treatment were reported by patients with returning visits of each treatment phase.

I hereby declare that the foregoing is an accurate summary of testing conducted under my control and supervision and that I am a disinterested third party with respect to Michael Kelly's tape.
- Donald E. Soli, M.D. February 23, 1993

Published in the TOWNSEND LETTER for DOCTORS - JUNE 1994 pages 606 -607

Copyright 2008 ThoughtForms Corporation All rights reserved.